TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Nitrates and Erectile Dysfunction Meds? Increasingly Common, …
WEBApr 20, 2022 · By L.A. McKeown. Despite widely publicized warnings about the potential interaction between nitrates prescribed for angina and oral (phosphodiesterase type 5) PDE5 inhibitors taken for erectile dysfunction, a Danish study suggests that prescriptions for the latter have steadily increased over the last 20 years in men who take nitrates, but ...
Welcome to TCTMD | tctmd.com
WEBOn behalf of CRF and TCTMD, we would like to extend a warm welcome to our community, which has developed over the past 20 years around a common goal to improve the survival and quality of life for people living with cardiovascular disease through research and education. We look forward to seeing you at our conferences and to working together to ...
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
Switching to Tenecteplase for Stroke Thrombolysis May Boost …
WEBSep 9, 2021 · Making the switch from alteplase to tenecteplase for stroke thrombolysis can be done successfully when the appropriate preparations are taken, and it may improve patient outcomes, the experience of a regional stroke network in New Zealand shows. Patients treated with tenecteplase had shorter door-to …
Olympic Hearts: Screening for CVD Among Team USA’s Athletes
WEBJul 31, 2024 · Olympic Hearts: Screening for CVD Among Team USA’s Athletes. In interviews with TCTMD, US cardiologists in that special role say care has shifted from paternalism to shared decision-making. As the Olympic Games gain steam in Paris, France, a small battalion of doctors, athletic trainers, physiotherapists, chiropractors, and psychologists are ...
Prudence or Spin? Mulling Embolic Protection After PROTECTED …
WEBOct 17, 2022 · PROTECTED TAVR, said Kaul, was designed to detect a 2% absolute risk difference or a 50% relative risk reduction. As such, “appropriate interpretation” would be that “the entire 95% confidence interval excluded the effect size that the study was powered to detect, which would put it in the category of being a negative trial,” he explained.
Conferences | tctmd.com
WEBSep 2, 2024 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
TCT Connect 2020 - TCTMD.com
WEBOct 14, 2020 · TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes. Presenter: Ehrin J. Armstrong. Presentation TCT 2020.